Valencia Technologies to Present its Clinical Data for the First Time at EuroPCR 2015

USA - English

• USA - Français

VALENCIA, Calif., May 18, 2015 /PRNewswire/ -- At EuroPCR 2015 in Paris, France, Valencia Technologies Corporation ("Valencia") will present for the first time its technology and clinical data to the scientific community on Tuesday, May 19, 2015.

Valencia's global principal investigator, Mark Webster, MD, of University of Auckland, will speak as part of the Cardiovascular Innovation Pipeline (Hypertension) session from 17:00 to 18:30 in Room 252A.   The title of the lecture is, "Neuromodulation by median nerve stimulation: a novel approach to refractory hypertension."  The conference is located at the Palais des Congres. 

Dr. Webster will speak about neuromodulation, about the science underlying this first device experience with median nerve stimulation for the treatment of hypertension, about Valencia's trial design, and about Valencia's clinical results in its near complete 48 person multicenter, double-blinded trial.

Valencia's coin-sized neurostimulator is one of several non-drug therapies for the treatment of resistant hypertension in clinical testing.  Other non-drug therapies include renal denervation and carotid baroreflex stimulation.  FDA has not yet approved for market a non-drug therapy to treat hypertension.

About Valencia

Valencia Technologies Corporation is a medical technology company located in Valencia, California.  Valencia has created a coin-sized device for the treatment of hypertension and other chronic conditions.  Implanted in the forearm during a 20-minute office procedure, the device will be tested in a pivotal trial to begin early 2016.

About EuroPCR

Planned annually by the European Society of Cardiology jointly and the European Association for Percutaneous Cardiovascular Interventions, EuroPCR is the leading world conference in interventional medicine.  The 2015 event is expected to host nearly 12,000 people at the Palais des Congres.  Topics covered include Medical, Surgery, Cardiology, Health, Medicine, Cardiovascular Diseases, Cardiovascular Research, Cardiostim, Acute Cardiovascular Care, Imaging, Echo, Echocardiography, Heart, Heart Care and much more.

For more information on Valencia, please visit the website: www.valenciatechnologies.com.

Find Valencia on:
LinkedIn
Facebook
Twitter
YouTube

Contact: Reid Gormly
Phone: +1-661- 775-1414
Cell: +1-661-289-1971
Email: [email protected]

Logo - http://photos.prnewswire.com/prnh/20150228/178551LOGO

SOURCE Valencia Technologies Corporation

Related Links

http://www.valenciatechnologies.com